Inj levocarnitine per 1 gm
Products billed under this code include Carnitor, Levocarnitine.
Payment limit per 1 GM, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Carnitor, Levocarnitine.
Payment limit per 1 GM, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Carnitor | Leadiant Biosciences, Inc. | 54482-0147-01 | 5 | $121.875 |
| Levocarnitine | Hikma Pharmaceuticals USA Inc. | 00143-9852-10 | 10 | $243.75 |
| Levocarnitine | American Regent, Inc. | 00517-1045-05 | 5 | $121.875 |
| Levocarnitine | American Regent, Inc. | 00517-1075-01 | 4 | $97.50 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $24.375 | +$1.768 | 1 GM | Inj levocarnitine per 1 gm | v1, posted September 17, 2026 |
| 3Q26 | $22.607 | −$0.48 | 1 GM | Inj levocarnitine per 1 gm | v1, posted September 15, 2026 |
| 2Q26 | $23.087 | −$0.181 | 1 GM | Inj levocarnitine per 1 gm | v1, posted September 15, 2026 |
| 1Q26 | $23.268 | −$0.339 | 1 GM | Inj levocarnitine per 1 gm | v1, posted September 15, 2026 |
| 4Q25 | $23.607 | −$0.685 | 1 GM | Inj levocarnitine per 1 gm | v1, posted September 8, 2026 |
| 3Q25 | $24.292 | −$0.084 | 1 GM | Inj levocarnitine per 1 gm | v1, posted March 10, 2026 |
| 2Q25 | $24.376 | −$1.187 | 1 GM | Inj levocarnitine per 1 gm | v1, posted March 10, 2026 |
| 1Q25 | $25.563 | −$2.158 | 1 GM | Inj levocarnitine per 1 gm | v1, posted December 19, 2025 |
| 4Q24 | $27.721 | −$2.821 | 1 GM | Inj levocarnitine per 1 gm | v1, posted June 11, 2025 |
| 3Q24 | $30.542 | −$4.594 | 1 GM | Inj levocarnitine per 1 gm | v1, posted June 11, 2025 |
| 2Q24 | $35.136 | −$0.185 | 1 GM | Inj levocarnitine per 1 gm | v1, posted March 11, 2025 |
| 1Q24 | $35.321 | −$0.117 | 1 GM | Inj levocarnitine per 1 gm | v1, posted December 19, 2024 |
| 4Q23 | $35.438 | +$0.023 | 1 GM | Inj levocarnitine per 1 gm | v1, posted October 10, 2024 |
| 3Q23 | $35.415 | +$1.249 | 1 GM | Inj levocarnitine per 1 gm | v1, posted June 5, 2024 |
| 2Q23 | $34.166 | +$3.945 | 1 GM | Inj levocarnitine per 1 gm | v1, posted February 23, 2024 |
| 1Q23 | $30.221 | +$2.185 | 1 GM | Inj levocarnitine per 1 gm | v1, posted December 6, 2023 |
| 4Q22 | $28.036 | +$2.661 | 1 GM | Inj levocarnitine per 1 gm | v1, posted June 22, 2023 |
| 3Q22 | $25.375 | +$2.916 | 1 GM | Inj levocarnitine per 1 gm | v1, posted June 9, 2023 |
| 2Q22 | $22.459 | +$0.698 | 1 GM | Inj levocarnitine per 1 gm | v1, posted December 14, 2022 |
| 1Q22 | $21.761 | +$0.703 | 1 GM | Inj levocarnitine per 1 gm | v1, posted June 8, 2022 |
| 4Q21 | $21.058 | +$0.066 | 1 GM | Inj levocarnitine per 1 gm | v1, posted June 2, 2022 |
| 3Q21 | $20.992 | −$0.081 | 1 GM | Inj levocarnitine per 1 gm | v1, posted June 2, 2022 |
| 2Q21 | $21.073 | +$0.083 | 1 GM | Inj levocarnitine per 1 gm | v1, posted March 1, 2022 |
| 1Q21 | $20.99 | – | 1 GM | Inj levocarnitine per 1 gm | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.